http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2325724-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a25fd564f2f598a86596e7c05fe0fd1 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-194 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-00 |
| filingDate | 2008-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4293ff9879c52ac12d64ade5fd2faf3c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f79510e27ce7010c8782c51eda59f850 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b740a75cdadbcfb03e02cc6e1c5a0ea4 |
| publicationDate | 2009-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2325724-A1 |
| titleOfInvention | PHARMACEUTICAL COMPOSITION TO INHIBIT THE INDUCABLE TRANSCRIPTION FACTOR BY HYPOXIA. MODULATORS OF PATHOLOGICAL PROCESSES OF ANGIOGENESIS, ONCOGENESIS, INFLAMMATION, APOPTOSIS AND CELL THERAPY. |
| abstract | Pharmaceutical composition to inhibit the factornof hypoxia-inducible transcription. Process modulatorsnpathological angiogenesis, oncogenesis, inflammation, apoptosis andncell therapy, which is included in the field of Pharmacology andnMedical Chemistry and refers to new molecules represented by thengeneral formula (I), especially the so-called FM19G11, as well asnto the pharmaceutical compositions that contain them. Thesenpharmacologically optimized compositions are able to modulatenand / or inhibit the transcription of genes modulated by the factor ofnhypoxia-inducible transcription (hereinafter, HIF) and that arendirectly and / or indirectly involved in pathological processesnrelated to cancer, inflammation, tissue repair,nstem cell differentiation and regenerative therapy. ThenThe present invention also relates to a method of synthesis ofnsaid molecules (I) and their use in the manufacture of anmedication for the treatment of pathological processesnmentioned. |
| priorityDate | 2008-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 576.